Fistulizing complications develop in approximately one third of patients with Crohn’s disease (CD), resulting in morbidity and impaired quality of life.


Therapy, Rectal Fistula, Cutaneous Fistula, Intestinal Fistula, Mesenchymal Stem Cell Transplantation, Crohn's Disease, Rectovaginal Fistula, therapeutic use, Urinary Fistula, Gastrointestinal Agents, Immunosuppressive Agents, Treatment Outcome, Physiopathology

Read More